ImmunoGen
IMGN
#2144
Rank
S$11.30 B
Marketcap
S$40.47
Share price
0.00%
Change (1 day)
126.65%
Change (1 year)

Market capitalization of ImmunoGen (IMGN)

Last known market cap: S$11.30 Billion

On April 12, 2024 ImmunoGen had a market cap of S$11.30 Billion. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of ImmunoGen from 2001 to 2024

End of year Market Cap

Year Marketcap Change
2024S$11.85 B13.14%
2023S$10.48 B614.06%
2022S$1.46 B-33.52%
2021S$2.20 B32.89%
2020S$1.66 B60.79%
2019S$1.03 B5.47%
2018S$0.97 B-13.59%
2017S$1.13 B339.89%
2016S$0.25 B-84.57%
2015S$1.67 B140.8%
2014S$0.69 B-56.41%
2013S$1.59 B21.25%
2012S$1.31 B14.51%
2011S$1.14 B41.27%
2010S$0.81 B28.31%
2009S$0.63 B102.94%
2008S$0.31 B21.63%
2007S$0.25 B-20.86%
2006S$0.32 B-7.74%
2005S$0.35 B-40.4%
2004S$0.58 B69.06%
2003S$0.34 B53.42%
2002S$0.22 B-81.4%
2001S$1.22 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Seagen
SGEN
S$55.92 B 394.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$230.20 B 1,936.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$1.173 T 10,281.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$137.57 B 1,116.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
S$630.46 B 5,476.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$191.79 B 1,596.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$328.62 B 2,806.71%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
S$156.67 B 1,285.78%๐Ÿ‡ซ๐Ÿ‡ท France